Results 1 to 10 of about 34,092 (295)

Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: An economic evaluation alongside a randomised controlled trial [PDF]

open access: yesPLoS ONE, 2014
Objective: To undertake an economic evaluation alongside the largest randomised controlled trial comparing Levonorgestrel-releasing intrauterine device ('LNG-IUS') and usual medical treatment for women with menorrhagia in primary care; and compare the ...
A Stewart   +23 more
core   +7 more sources

Exploring the Use of Cost-Benefit Analysis to Compare Pharmaceutical Treatments for Menorrhagia [PDF]

open access: yes, 2015
Background: The extra-welfarist theoretical framework tends to focus on health-related quality of life, whilst the welfarist framework captures a wider notion of well-being.
D Husereau   +24 more
core   +4 more sources

Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding : systematic review and meta-analysis of data from individual patients [PDF]

open access: yes, 2010
Peer reviewedPublisher ...
J. P. Daniels   +10 more
core   +2 more sources

Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding : cost effectiveness analysis [PDF]

open access: yes, 2011
Peer reviewedPublisher ...
Barton, P M   +7 more
core   +2 more sources

An integrated care pathway for menorrhagia across the primary–secondary interface : patients' experience, clinical outcomes, and service utilisation [PDF]

open access: yes, 2007
Background: ‘‘Referral’’ characterises a significant area of interaction between primary and secondary care. Despite advantages, it can be inflexible, and may lead to duplication.
Baker, Richard   +7 more
core   +2 more sources

Successful treatment of refractory gastrointestinal bleeding by systemic (oral) ankaferd blood stopper in a patient with Glanzmann thrombasthenia [PDF]

open access: yes, 2015
Background: Glanzmann Thrombasthenia (GT) is a genetic platelet dysfunction and a life threatening disease. Ankaferd Blood Stopper (ABS) is a topical hemostatic agent of herbal origin which has been recently made available for clinical use.
Doğu, Mehmet Hilmi   +3 more
core   +2 more sources

Unusual cause of menorrhagia [PDF]

open access: yesBMJ Case Reports, 2013
A 37-year-old woman presented to her general practitioner (GP) with a history of intermittent galactorrhoea and amenorrhoea. She reported intermittent expression (5 mL) from both breasts, which have been present following her last pregnancy 4 years ago.
Charles Anwuzia-Iwegbu, Scott Akker
openaire   +3 more sources

Diagnosis of von Willebrand disease in Argentina: a single institution experience [PDF]

open access: yes, 2017
von Willebrand disease (VWD) is the most common autosomal bleeding disorder, mostlyinherited as dominant trait. VWD is due to deficiency/abnormality of von Willebrand factor (VWF).
Blanco, Alicia Noemi   +5 more
core   +1 more source

Clinical profile of patients with menorrhagia and its correlation with endometrial histopathology and sonographic features [PDF]

open access: yes, 2019
Background: Menorrhagia is one of the most common gynecologic complaints in contemporary gynecology. It is defined as total blood loss exceeding 80 ml per cycle or menses lasting longer than 7 days.
Bhardwaj, Bikram, Rath, S. K.
core   +2 more sources

Home - About - Disclaimer - Privacy